Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review

Muhammad Usman Ali1, Donna Fitzpatrick-Lewis2, Meghan Kenny1

  • 1McMaster Evidence Review and Synthesis Centre, McMaster University, 1280 Main St. W., McMaster Innovation Park, Room 207A, Hamilton, Ontario, L8S 4K1, Canada; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Room HSC-2C, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada.

Resuscitation
|September 5, 2018
PubMed

Insights

Antiarrhythmic drugs show no benefit for survival in shockable cardiac arrest. Lidocaine may improve return of spontaneous circulation, but more research is needed for critical outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Cardiac arrest management guidelines emphasize timely interventions.
  • Antiarrhythmic drugs are frequently used in advanced cardiac life support protocols.
  • Evidence on their effectiveness in shockable cardiac arrest requires regular updates.

Purpose of the Study:

  • To systematically review current evidence on antiarrhythmic drug efficacy in shockable cardiac arrest.
  • To inform the 2018 International Liaison Committee on Resuscitation Consensus on Science with Treatment Recommendations.
  • To evaluate outcomes such as survival and neurological function.

Main Methods:

  • Comprehensive search of Medline, Embase, and Cochrane Library databases.
  • Inclusion of randomized controlled trials (RCTs) and observational studies up to August 2017.
  • Analysis of adult and pediatric populations separately.

Main Results:

  • RCTs in adults found no significant difference for antiarrhythmic drugs versus placebo for survival to discharge or good neurological function.
  • Lidocaine showed a statistically significant increase in return of spontaneous circulation compared to placebo (RR=1.16; 95% CI, 1.03-1.29).
  • Limited evidence exists for pediatric populations and specific post-resuscitation scenarios.

Conclusions:

  • High-level evidence for antiarrhythmic drug benefit in shockable cardiac arrest is limited.
  • No demonstrated benefit for critical outcomes like survival or neurological function.
  • Further research is essential to clarify the role of these drugs, especially in pediatric cases and post-ROSC adults.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.2K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.9K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.5K